Donate
Multidrug Resistance 1 (MDR1)
Breed: McNab
Generic Phene Data
Breeds
Relevance Rating: There is strong evidence or research available for these breeds
Relevance Rating: There is moderate evidence or research available for these breeds
Relevance Rating: There is some evidence or research available for these breeds
Relevance Rating: The test is unknown, there is no evidence (i.e. research) available, or it has not been evaluated yet. These tests may or may not be meaningful for these breeds
General
Disease Name
Multidrug Resistance 1 (MDR1)
OMIA
1402
Gene Name
ABCB1
Gene Name 2
CanFam 3.1, Chr. 14
Mutation
c.296_299del4
Mutation 2
c.295_298del
Mutation 3
g.13726596_13726599del
Mutation 4
c.228_231del
Test Type
Diagnostic Tool
Details
Multi-Drug Resistance Gene, (MDR) codes for a protein that is responsible for protecting the brain by transporting potentially harmful chemicals away from the brain. In certain breeds, a mutation in the MDR1 gene causes sensitivity to Ivermectin, Loperamide, and a number of other drugs. As a result of the accumulation of toxins, the dog can show neurological symptoms including: ataxia, tremors, seizures, excessive salivation, obtundation, bradycardia, mydriasis, loss of menace, loss of papillary light responses, coma and respiratory arrest. Age of onset from birth, but symptoms only noted when exposed to drugs causing sensitivity.There are many different types of drugs that have been reported to cause problems. Some drugs include: Acepromazine, Butorphanol, Cyclosporin, Digoxin, Doxorubicin, Doramectin, Emodepside, Erythromycin, Ivermectin, Loperamide (Imodium), Milbemycin, Moxidectin, Paclitaxel, Rifampin, Selamectin, Vinblastine, Vincristine. Please note this list is not exhaustive and could be subject to change.
Details 2
Multidrug resistance 1 is caused by a lack of P-glycoprotein drug transporter in the blood-brain barrier, which is characterized by neurotoxicity after administration of certain drugs. A genetic test is available. Neurotoxicity following drug administration, which varies according to dose, is the main sign. Dogs may show ataxia, tremors, seizures, excessive salivation, obtundation, bradycardia, mydriasis, loss of menace, loss of papillary light responses, coma and respiratory arrest (Mealey et al., 2001). P-gp normally transports some chemotherapeutic agents (Vinca alkaloids, doxorubicin), immunosuppressants (cyclosporine, tacrolimus), macrocyclic lactone antiparasitic drugs (ivermectin, loperamide, milbemycin, selamectin, moxidectin), HIV-1 protease inhibitors, and steroid hormones. (From OMIA)
Patents/ Licences
Washington State University owns Patent on MDR1 genotyping: US 6790621. Wisdom Health is the only entity licensed to perform MDR1 genotyping in conjunction with breed analysis and genetic screening for multiple diseases and traits in the United States
Application Information
Published
Mealey, KL., Bentjen, SA., Gay, JM., Cantor, GH. : Ivermectin sensitivity in collies is associated with a deletion mutation of the mdr1 gene. Pharmacogenetics 11:727-33, 2001. Pubmed reference: 11692082.
Published 2
Mizukami, K., Yabuki, A., Kohyama, M., Kushida, K., Rahman, M.M., Uddin, M.M., Sawa, M., Yamato, O. : Molecular prevalence of multiple genetic disorders in Border collies in Japan and recommendations for genetic counselling. Vet J 214:21-3, 2016. Pubmed reference: 27387721. DOI: 10.1016/j.tvjl.2016.05.004.
Published 3
Donner J, Kaukonen M, Anderson H, Moller F, Kyostila K, Sankari S, Hytonen M, Giger U, Lohi H. Genetic Panel Screening of Nearly 100 Mutations Reveals New Insights into the Breed Distribution of Risk Variants for Canine Hereditary Disorders. PLoS One. 2016 Aug 15;11(8):e0161005. [PubMed: 27525650]
Published 4
Gramer, I., Leidolf, R., Doring, B., Klintzsch, S., Kramer, EM., Yalcin, E., Petzinger, E., Geyer, J. : Breed distribution of the nt230(del4) MDR1 mutation in dogs. Vet J 189:67-71, 2011. Pubmed reference: 20655253. DOI: 10.1016/j.tvjl.2010.06.012.
Body/System/Process
Blood
OMIA Url
Inheritance
AR
Phene Discovery
The discovery of the MDR1 mutation in dogs, establishment of genotyping procedures, development of all reagents, and research into specific problem drugs was made or conducted by Washington State University.
Breed Specific Info
Researched Breeds
Border Collie, Australian Shepherd, Collie, German Shepherd Dog, Longhaired Whippet, Miniature Australian Shepherd, Old English Sheepdog, Shetland Sheepdog, Silken Windhound, Waller, White Swiss Shepherd
HSP Test-Specific Data
Agrotis S.r.l.
GTP
GTP Name
Agrotis S.r.l.
Breed
OMIA
Gene Name
ABCB1
Mutation
c.295_298del; c.296_299del4
BioBank AS
GTP
GTP Name
BioBank AS
Breed
OMIA
Gene Name
ABCB1
Mutation
c.295_298del; c.296_299del4
Certagen GmbH
GTP
GTP Name
Certagen GmbH
Breed
OMIA
Gene Name
ABCB1
Mutation
c.295_298del; c.296_299del4
CMSCH
GTP
GTP Name
CMSCH
Breed
OMIA
Gene Name
ABCB1
Mutation
c.295_298del; c.296_299del4
DNA My Dog
GTP
GTP Name
DNA My Dog
Breed
OMIA
GTP Disease Name
Ivermectin Sensitivity
Gene Name
ABCB1
Mutation
c.295_298del
Nature of test
mutation test
This test is outsourced to:
Orivet
FCI Number
-49
GTP Breed
McNab
EVG Diagnostics
GTP
GTP Name
EVG Molecular Diagnostics
Breed
OMIA
Gene Name
MDR1 (ABCB1)
Mutation
c.295_298del
INNO
GTP
GTP Name
INNO
Breed
OMIA
Gene Name
ABCB1
Mutation
c.295_298del; c.296_299del4
Laboratorios Labocor S.L.
GTP
GTP Name
Laboratorios Labocor S.L.
Breed
OMIA
Gene Name
ABCB1
Mutation
c.295_298del; c.296_299del4
Laboklin Gmbh & Co. KG
GTP
GTP Name
Laboklin Gmbh & Co. KG
Breed
OMIA
GTP Disease Name
Ivermectin Sensitivity
Gene Name
ABCB1
Mutation
c.295_298del
Nature of test
mutation test
FCI Number
-49
GTP Breed
McNab
Orivet Genetic Pet Care
GTP
GTP Name
Orivet Genetic Pet Care
Breed
OMIA
GTP Disease Name
Ivermectin Sensitivity
Gene Name
ABCB1
Mutation
c.295_298del
Nature of test
mutation test
FCI Number
-49
GTP Breed
McNab
PharmaDNA
GTP
GTP Name
PharmaDNA
Breed
OMIA
Gene Name
ABCB1
Mutation
c.295_298del; c.296_299del4
Progènes-ADN
GTP
GTP Name
Progenes ADN
Breed
OMIA
Gene Name
ABCB1
Mutation
c.295_298del; c.296_299del4
Veterinary Clinical Pharmacology Laboratory (VCPL)
GTP
GTP Name
Veterinary Clinical Pharmacology Laboratory
Breed
OMIA
GTP Disease Name
Ivermectin Sensitivity
Gene Name
ABCB1
Mutation
c.296_299del4
Nature of test
mutation test
GTP Patents/ Licences/ Discovery
Washington State University owns Patent on MDR1 genotyping: US 6790621
VHL Genetics
GTP
GTP Name
VHL Genetics
Breed
OMIA
Gene Name
ABCB1
Mutation
c.295_298del; c.296_299del4
Wisdom Panel - Kinship
GTP
GTP Name
Wisdom Panel - Kinship
Breed
OMIA
GTP Disease Name
Ivermectin Sensitivity
Gene Name
ABCB1
Mutation
c.295_298del
Nature of test
mutation test
FCI Number
-49
GTP Breed
McNab
Zoolyx
GTP
GTP Name
Zoolyx
Breed
OMIA
Gene Name
ABCB1
Mutation
c.295_298del; c.296_299del4
-
HGTD Quick Search
-
The portal for Genetic Testing Providers (labs); genetic tests, and tests by breed: as well as information on quality indicators and genetic counseling resources.
GOAL: Robust genetic testing supporting health improvements & a sustainable future for healthy dogs. -
HGTD Database Resources
How to use the HGTD
Using HGTD - YouTube Videos
HGTD Quality Indicators
Acronyms - Mode of Inheritance♦ 2020-New What is a Relevance Rating?
FAQs
Answers to frequently asked questions about the HGTD
Accreditation Basics
This brief overview may help you identify what types of accreditation are important to you, when choosing your genetic test provider.
Accreditation and Industry Standards
List of organizations throughout the world that are involved in matters of accreditation and establishing industry standards.
Choosing a Genetic Test Provider
Choosing a genetic test provider can be daunting. This short article helps you to consider what is important to you, and your dogs, in finding the right test provider for you. -
The HGTD's genetic counselling resources index provides access to basic introductory articles on genetics, articles on application of genetics in breed health management, and advanced work in technical genetics research. Breed-specific information is also available in our Pedigreed Dogs Database.
